NDC properties for "Revlimid 15 MG Oral Capsule" (RxCUI 643714)
About this data
The tables show NDC propoerties for Revlimid 15 MG Oral Capsule with the RxCUI 643714
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Revlimid 15 MG Oral Capsule (RxCUI 643714)
| MMSL_CODE | BD16977 |
|---|---|
| NDA | NDA021880 |
| RxCUI | 643714 |
| SPL_SET_ID | 5fa97bf5-28a2-48f1-8955-f56012d296be |
| Prescribable Synonym | Revlimid 15 MG Oral Capsule |
| RXNAV_STR | Revlimid 15 MG Oral Capsule |
| RxNorm Name | lenalidomide 15 MG Oral Capsule [Revlimid] |
| RxNorm Synonym | Revlimid 15 MG Oral Capsule |
| Related queries | Interactions (for RxCUI 643714) |
NDC Properties
NDC Item 59572041500
| NDC 9 | 59572-415 |
|---|---|
| NDC 10 | 59572-415-00 |
| NDC Item | 59572041500 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-415-00) |
| COLORTEXT | BLUE,WHITE |
| Color | C48333;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;15;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-415 |
NDC Item 59572041521
| NDC 9 | 59572-415 |
|---|---|
| NDC 10 | 59572-415-21 |
| NDC Item | 59572041521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59572-415-21) |
| COLORTEXT | BLUE,WHITE |
| Color | C48333;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;15;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-415 |
NDC Item 59572041500
| NDC 9 | 59572-415 |
|---|---|
| NDC 10 | 59572-415-00 |
| NDC Item | 59572041500 |
| Packaging | 100 CAPSULE in 1 BOTTLE (59572-415-00) |
| COLORTEXT | BLUE,WHITE |
| Color | C48333;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;15;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-415 |
NDC Item 59572041521
| NDC 9 | 59572-415 |
|---|---|
| NDC 10 | 59572-415-21 |
| NDC Item | 59572041521 |
| Packaging | 21 CAPSULE in 1 BOTTLE (59572-415-21) |
| COLORTEXT | BLUE,WHITE |
| Color | C48333;C48325 __ |
| FDA SPL set id | 704914 |
| Imprint code | REV;15;mg |
| Labeler | Celgene Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2006-06-29 |
| Marketing status | ACTIVE |
| NDA | NDA021880 |
| Score | 1 |
| Shape | C48336 |
| Size | 22 mm |
| Related queries | Properties for NDC 9 59572-415 |